Suchergebnisse - "Yang, Nong"

PubPharm (21)

1

Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China

enthalten in: Thoracic cancer | 2023

von Pu, X. | Xu, C. | Wang, Q. | +98

2

Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer : a pooled analysis from two phase 2 studies

enthalten in: BMC medicine | 2023

von Hu, X. | Zhang, S. | Ma, Z. | +27

3

Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies

enthalten in: BMC medicine | 2023

von Hu, X. | Zhang, S. | Ma, Z. | +27

4

Central Nervous System Efficacy of Furmonertinib (AST2818) Versus Gefitinib as First-Line Treatment for EGFR-Mutated NSCLC : Results From the FURLONG Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Shi, Y. | Chen, G. | Wang, X. | +19

5

Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations : a phase II efficacy and biomarker study

enthalten in: BMC cancer | 2022

von Zhang, Y. | Song, L. | Zeng, L. | +9

6

Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study

enthalten in: BMC cancer | 2022

von Zhang, Y. | Song, L. | Zeng, L. | +9

7

Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study

enthalten in: BMC cancer | 2022

von Zhang, Y. | Song, L. | Zeng, L. | +9

8

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma : A retrospective-real world study

enthalten in: Frontiers in oncology | 2022

von Huang, Z. | Zhou, C. | Xiong, Y. | +9

9

Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non-Small Cell Lung Cancer

enthalten in: Frontiers in pharmacology | 2022

von Liao, D. | Yu, L. | Shangguan, D. | +4

10

Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis

enthalten in: Microbiology spectrum | 2021

von Lu, H. | Gao, N. | Tong, F. | +11